Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases ; day:5 ; month:9 ; year:2016 ; pages:1-7
Drugs - real world outcomes ; (5.9.2016), 1-7
- Creator
-
Mourot-Cottet, Rachel
- Contributor
-
Maloisel, Fréderic
Severac, François
Keller, Olivier
Vogel, Thomas
Tebacher, Martine
Weber, Jean-Christophe
Kaltenbach, Georges
Gottenberg, Jacques-Eric
Goichot, Bernard
Sibilia, Jean
Korganow, Anne-Sophie
Herbrecht, Raoul
Andres, Emmanuel
SpringerLink (Online service)
- DOI
-
10.1007/s40801-016-0091-4
- URN
-
urn:nbn:de:1111-201610045365
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mourot-Cottet, Rachel
- Maloisel, Fréderic
- Severac, François
- Keller, Olivier
- Vogel, Thomas
- Tebacher, Martine
- Weber, Jean-Christophe
- Kaltenbach, Georges
- Gottenberg, Jacques-Eric
- Goichot, Bernard
- Sibilia, Jean
- Korganow, Anne-Sophie
- Herbrecht, Raoul
- Andres, Emmanuel
- SpringerLink (Online service)
Other Objects (12)
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?
Financial Crises: Systemic or Idiosyncratic
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?
Financial Crises: Systemic or Idiosyncratic
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
Human leucocyte antigen genetics in idiosyncratic drug-induced liver Injury with evidence based on the Roussel Uclaf causality assessment method
Advances in idiosyncratic drug-induced liver injury issues: new clinical and mechanistic analysis due to Roussel Uclaf Causality Assessment Method use
Is idiosyncratic risk conditionally priced?